195 related articles for article (PubMed ID: 10509077)
1. Difference in virulence and resistance to pyrazinamide between M. bovis and M. tuberculosis.
van Loenhout-Rooyackers JH
Neth J Med; 1999 Sep; 55(3):163. PubMed ID: 10509077
[No Abstract] [Full Text] [Related]
2. [Biological properties of selected drug-resistant strains of Mycobacterium tuberculosis].
Afanas'eva IuP; Zagorzhinskiĭ PIu
Probl Tuberk; 1978 Oct; (10):65-70. PubMed ID: 101985
[No Abstract] [Full Text] [Related]
3. Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis.
Ahmad Z; Tyagi S; Minkowsk A; Almeida D; Nuermberger EL; Peck KM; Welch JT; Baughn AS; Jacobs WR; Grosset JH
Indian J Med Res; 2012 Nov; 136(5):808-14. PubMed ID: 23287128
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to pyrazinamide.
Ghiraldi LD; Campanerut PA; Spositto FL; Sato DN; Leite CQ; Hirata M; Hirata RD; Cardoso RF
Clin Microbiol Infect; 2011 Dec; 17(12):1792-7. PubMed ID: 21595790
[TBL] [Abstract][Full Text] [Related]
5. Pyrazinamide susceptibility testing in all isolates of the Mycobacterium tuberculosis complex - a critical analysis.
Cunha J
Rev Port Pneumol; 2012; 18(4):188-9. PubMed ID: 22257727
[No Abstract] [Full Text] [Related]
6. [Biological properties of laboratory strains and clinical isolates of mycobacteria multiresistant to antitubercular preparations].
Korneev AA; Golyshevskaia VI; Sevast'ianova EV; Safonova SG; Puzanov VA
Probl Tuberk; 1999; (2):44-7. PubMed ID: 10420752
[TBL] [Abstract][Full Text] [Related]
7. Detection of a streptomycin-resistant Mycobacterium bovis strain through antitubercular drug susceptibility testing of Tunisian Mycobacterium tuberculosis complex isolates from cattle.
Djemal SE; Camperio C; Armas F; Siala M; Smaoui S; Messadi-Akrout F; Gdoura R; Marianelli C
BMC Vet Res; 2018 Sep; 14(1):296. PubMed ID: 30268120
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide.
Aragón LM; Garrigó M; Moreno C; Español M; Coll P
J Antimicrob Chemother; 2007 Sep; 60(3):655-7. PubMed ID: 17615155
[TBL] [Abstract][Full Text] [Related]
9. Does resistance to pyrazinamide accurately indicate the presence of Mycobacterium bovis?
de Jong BC; Onipede A; Pym AS; Gagneux S; Aga RS; DeRiemer K; Small PM
J Clin Microbiol; 2005 Jul; 43(7):3530-2. PubMed ID: 16000498
[TBL] [Abstract][Full Text] [Related]
10. Conventional and molecular determination of drug resistance in Mycobacterium tuberculosis and Mycobacterium bovis isolates in cattle.
Sweetline Anne N; Ronald BSM; Senthil Kumar TMA; Thangavelu A
Tuberculosis (Edinb); 2019 Jan; 114():113-118. PubMed ID: 30711149
[TBL] [Abstract][Full Text] [Related]
11. [Pleural and peritoneal tuberculosis due to Mycobacterium bovis].
Garre A; Ortega López N; Pérez R; Molina M
Enferm Infecc Microbiol Clin; 2015 Apr; 33(4):288-9. PubMed ID: 25200214
[No Abstract] [Full Text] [Related]
12. [Isolation of mutants resistant to antituberculous drugs in wild strains of M. bovis].
de Kantor IN; Lesslie IW
Medicina (B Aires); 1974; 34(3):244-8. PubMed ID: 4212693
[No Abstract] [Full Text] [Related]
13. In vitro antimycobacterial activity of 5-chloropyrazinamide.
Cynamon MH; Speirs RJ; Welch JT
Antimicrob Agents Chemother; 1998 Feb; 42(2):462-3. PubMed ID: 9527809
[TBL] [Abstract][Full Text] [Related]
14. Treatment of human disease due to Mycobacterium bovis: a systematic review.
Lan Z; Bastos M; Menzies D
Eur Respir J; 2016 Nov; 48(5):1500-1503. PubMed ID: 27540021
[No Abstract] [Full Text] [Related]
15. The susceptibility of mycobacteria to rifamide and rifampicin.
Clark J; Wallace A
Tubercle; 1967 Jun; 48(2):144-8. PubMed ID: 4293697
[No Abstract] [Full Text] [Related]
16. Treatment of Mycobacterium bovis infected tuberculosis patients: San Diego County, California, United States, 1994-2003.
LoBue PA; Moser KS
Int J Tuberc Lung Dis; 2005 Mar; 9(3):333-8. PubMed ID: 15786900
[TBL] [Abstract][Full Text] [Related]
17. [Incidence of primary and secondary resistance of M. tuberculosis in East Germany in 1983 in hospitalized patients].
Kalich R; Käppler W
Z Erkr Atmungsorgane; 1986; 167(3):254-60. PubMed ID: 3105189
[TBL] [Abstract][Full Text] [Related]
18. [Antitubercular effect of capreomycin in vitro].
Janowiec M
Gruzlica; 1969 Jul; 37(7):629-35. PubMed ID: 4981783
[No Abstract] [Full Text] [Related]
19. Sensitivity testing of Mycobacteria to the riminophenazine B 663.
Thomson DS; Wallace A
Tubercle; 1968 Mar; 49(1):42-7. PubMed ID: 4969146
[No Abstract] [Full Text] [Related]
20. Tuberculosis drug resistance: summary report for 2003.
Can Commun Dis Rep; 2004 May; 30(10):93-5. PubMed ID: 15174496
[No Abstract] [Full Text] [Related]
[Next] [New Search]
